PNOĒ Launches Self‑Service Breath Mask for Gyms, Offers Lab‑Grade VO₂ Max in Minutes

Malden, Massachusetts‑based health‑tech startup PNOĒ is set to introduce a new version of its breath‑analyzing face mask on October 1, aimed at fitness centers and solo athletes seeking rapid, laboratory‑grade metabolic information without the need for a technician.

The refreshed device, which the company describes as a “sleeker, self‑serve” mask, can calculate a wearer’s VO₂ max along with several other metabolic indicators in roughly eight minutes. By examining the makeup of exhaled air, the system converts breath chemistry into metrics that are normally obtained from treadmill or cycle‑ergometer tests that require specialized gear and trained personnel.

PNOĒ’s first mask, notable for its dramatic Bane‑inspired look, was primarily marketed as a research‑grade instrument for clinical environments. The new iteration pares down the visual flair and incorporates a user‑friendly interface that walks users through a brief breathing sequence before showing results on an integrated screen or a companion app.

Trainers and fitness coaches view the technology as a possible game‑changer for personal‑training sessions and group classes. Precise VO₂ max measurements enable assessment of cardiovascular fitness, definition of suitable training zones, and monitoring of progress over time. By compressing what once required a lab visit into an eight‑minute in‑gym check, the mask could streamline performance evaluations and lessen dependence on outside testing services.

Observers note that the launch fits within a larger shift toward consumer‑direct health monitoring, where gadgets such as wearable heart‑rate trackers and blood‑oxygen sensors have become routine. Breath analysis, however, remains a relatively niche field, and PNOĒ’s assertion of “lab‑grade” accuracy is likely to attract scrutiny from regulators and the scientific community alike.

Regulatory routes for breath‑based diagnostics differ across regions, yet the company has clarified that the mask is intended for wellness and fitness purposes rather than medical diagnosis. This positioning could ease market entry while still providing data that athletes and coaches can weave into training programs.

Selected pilot gyms will receive early units for testing before the public rollout, offering feedback on ease of use, data reliability, and compatibility with existing fitness platforms. PNOĒ plans to broaden distribution through equipment vendors and possibly direct‑to‑consumer channels later in the year.

Should the product meet its claims, it may democratize high‑resolution metabolic testing, enabling more individuals to customize workouts based on exact physiological feedback. The launch will also act as a barometer for how swiftly the fitness sector adopts breath‑based analytics as a standard metric alongside heart rate and power output.